These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 10754464)

  • 1. Serum level of HER-2/neu in patients with gastric cancer: correlation with HER-2/neu overexpression in gastric carcinoma tissue.
    Kono K; Naganuma H; Sekikawa T; Amemiya H; Takahashi A; Iizuka H; Matsumoto Y
    Tumour Biol; 2000; 21(3):139-44. PubMed ID: 10754464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of TFF3 protein and Her-2/neu status in patients with gastric adenocarcinoma.
    Xu CC; Yue L; Wei HJ; Zhao WW; Sui AH; Wang XM; Qiu WS
    Pathol Res Pract; 2013 Aug; 209(8):479-85. PubMed ID: 23822993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ADAM 10 is associated with gastric cancer progression and prognosis of patients.
    Wang YY; Ye ZY; Li L; Zhao ZS; Shao QS; Tao HQ
    J Surg Oncol; 2011 Feb; 103(2):116-23. PubMed ID: 21259244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study of pretreatment serum levels of HER-2/neu oncoprotein as a prognostic and predictive factor in patients with advanced nonsmall cell lung carcinoma.
    Ardizzoni A; Cafferata MA; Paganuzzi M; Filiberti R; Marroni P; Neri M; Fontana V; Nicoló G; Perdelli L; Stampino CG; Rosso R; Puntoni R
    Cancer; 2001 Oct; 92(7):1896-904. PubMed ID: 11745263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Her-2/neu assessment for gastric carcinoma: validation of scoring system.
    Mrklic I; Bendic A; Kunac N; Bezic J; Forempoher G; Durdov MG; Karaman I; Prusac IK; Pisac VP; Vilovic K; Tomic S
    Hepatogastroenterology; 2012; 59(113):300-3. PubMed ID: 22260838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathologic Implications of Eukaryotic Initiation Factor 3f and Her-2/neu Expression in Gastric Cancer.
    Cheng Y; Zhou J; Li H
    Clin Transl Sci; 2015 Aug; 8(4):320-5. PubMed ID: 25684180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathologic and prognostic significance of overexpression of her-2/neu and p53 oncoproteins in gastric carcinoma using tissue microarray.
    Ismail HM; Moneer M; El-Baradie M; Khorshid O; Touny A
    J Egypt Natl Canc Inst; 2007 Jun; 19(2):147-57. PubMed ID: 19034345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Signal transduction proteins in tumors from Puerto Rican and Caucasian gastric adenocarcinoma patients: expression differences with potential for specific targeted therapies.
    Cangiano J; Centeno BA; Garrett CR; Cáceres W; de Jesús A; Lee JH; Pavía O; Jove R; Báez L; Sullivan DM; Muro-Cacho CA; Muñoz-Antonia T
    Dig Dis Sci; 2008 Aug; 53(8):2090-100. PubMed ID: 18224443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathologic significance of HER-2/neu protein expression and gene amplification in gastric carcinoma.
    Yan SY; Hu Y; Fan JG; Tao GQ; Lu YM; Cai X; Yu BH; Du YQ
    World J Gastroenterol; 2011 Mar; 17(11):1501-6. PubMed ID: 21472111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HER-2/neu amplification is an independent prognostic factor in gastric cancer.
    Park DI; Yun JW; Park JH; Oh SJ; Kim HJ; Cho YK; Sohn CI; Jeon WK; Kim BI; Yoo CH; Son BH; Cho EY; Chae SW; Kim EJ; Sohn JH; Ryu SH; Sepulveda AR
    Dig Dis Sci; 2006 Aug; 51(8):1371-9. PubMed ID: 16868827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlations of β-catenin, Ki67 and Her-2/neu with gastric cancer.
    Wu HW; Qin CY; Huang JL; Kong XY; Wang WJ; Bai WK
    Asian Pac J Trop Med; 2014 Apr; 7(4):257-61. PubMed ID: 24507671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of epithelial-cadherin and human epidermal growth factor receptor 2/ expression in gastric carcinoma using immunohistochemistry.
    Dewan K; Madan R; Sengupta P; Bharadwaj R
    Indian J Pathol Microbiol; 2015; 58(2):154-7. PubMed ID: 25885125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunohistochemical study of p53, c-erbB-2 and nm23 proteins in human gastric cancer].
    Wei Z; Wu Y; Zhai Z
    Zhonghua Zhong Liu Za Zhi; 1997 Sep; 19(5):378-81. PubMed ID: 10920922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HER-2/neu overexpression is an independent prognostic factor for intestinal-type and early-stage gastric cancer patients.
    Liu W; Zhong S; Chen J; Yu Y
    J Clin Gastroenterol; 2012 Apr; 46(4):e31-7. PubMed ID: 22064554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of c-erbB-2 oncoprotein expression in tissue and serum of patients with stomach cancer.
    Chariyalertsak S; Sugano K; Ohkura H; Mori Y
    Tumour Biol; 1994; 15(5):294-303. PubMed ID: 7991990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognosis significance of HER-2/neu overexpression/amplification in Chinese patients with curatively resected gastric cancer after the ToGA clinical trial.
    Zhou F; Li N; Jiang W; Hua Z; Xia L; Wei Q; Wang L
    World J Surg Oncol; 2012 Dec; 10():274. PubMed ID: 23249720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Association of HER-2/neu expression with prognosis of gastric cancer].
    Chen B; Luo RC; Cui F; Qian XY
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Mar; 26(3):344-7. PubMed ID: 16546744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum HER2 levels and HER2 status in tumor cells in advanced gastric cancer patients.
    Sasaki T; Fuse N; Kuwata T; Nomura S; Kaneko K; Doi T; Yoshino T; Asano H; Ochiai A; Komatsu Y; Sakamoto N; Ohtsu A
    Jpn J Clin Oncol; 2015 Jan; 45(1):43-8. PubMed ID: 25378649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HER-2/neu and TOPIIa expression in gastric cancer reflect disease severity.
    Liu HQ; Zhang SL; Song S
    Hepatogastroenterology; 2012 Jun; 59(116):1290-3. PubMed ID: 22281973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is Helicobacter Pylori associated with Her2/neu Overexpression in Gastric Cancer Patients who Underwent Curative Resection?
    Yoo MW; Han HS; Kim SY; Cho YH; Lee HG; Kim JH; Bang HY; Lee KY; Yoon SY
    Hepatogastroenterology; 2014 May; 61(131):858-62. PubMed ID: 26176087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.